H.R. 6561

[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 6561 Introduced in House (IH)]

<DOC>

119th CONGRESS
1st Session
H. R. 6561

To amend the Public Health Service Act to provide for a public 
awareness campaign with respect to human papillomavirus, and for other 
purposes.

_______________________________________________________________________

IN THE HOUSE OF REPRESENTATIVES

December 10, 2025

Ms. Castor of Florida (for herself, Mr. Bacon, and Ms. Schrier) 
introduced the following bill; which was referred to the Committee on 
Energy and Commerce

_______________________________________________________________________

A BILL

To amend the Public Health Service Act to provide for a public 
awareness campaign with respect to human papillomavirus, and for other 
purposes.

Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

This Act may be cited as the ``Promoting Resources to Expand 
Vaccination, Education and New Treatments for HPV Cancers Act of 2025'' 
or the ``PREVENT HPV Cancers Act of 2025''.

SEC. 2. FINDINGS.

Congress finds the following:
(1) The human papillomavirus (referred to in this Act as 
``HPV'') causes six different types of cancer (anal, cervical, 
oropharynx, penile, vaginal, and vulvar).
(2) Approximately 39,300 cases of cancer are caused by HPV 
each year impacting both women and men.
(3) About 91 percent of cervical and anal cancers are 
thought to be caused by HPV.
(4) Black and Hispanic women are more likely to get HPV-
associated cervical cancer than women of other races and 
ethnicities due to disparities in access to cancer screening 
and early detection.
(5) New cases of cervical cancer decreased among women in 
young age groups, likely due to HPV vaccination, but in recent 
years, new cases of cervical cancer rates among women in older 
age groups have plateaued or, in the case of women ages 30-34, 
increased.
(6) Cervical cancer screening has declined and there has 
been an increase in cervical cancer diagnosed at distant 
stages, which are more difficult to treat and more likely to 
recur, leading to greater morbidity and mortality.
(7) Approximately 70 percent of oropharyngeal cancer is 
tied to HPV, and such cancers are more than twice as common in 
men as in women.
(8) Most HPV infections that can lead to cancer can be 
prevented by vaccines.
(9) HPV vaccines can also help prevent recurrent 
respiratory papillomatosis, anal and genital warts.
(10) Vaccination for HPV is approved for men and women.
(11) The vaccines are most effective if administered when 
an individual is between the ages of 9 and 12, but the vaccines 
are licensed for men and women through age 45.
(12) Approximately 63 percent of adolescents have completed 
the HPV vaccine series, a lower rate than other routine 
recommended vaccinations.
(13) Adolescents living in rural areas continue to be less 
likely to have initiated and completed the HPV vaccine series 
than those living in urban areas.
(14) Health providers' recommendation of the vaccine is 
critical to getting adolescents vaccinated.

SEC. 3. HPV CANCER PREVENTION PUBLIC AWARENESS CAMPAIGN.

(a) In General.--Section 317 of the Public Health Service Act (42 
U.S.C. 247b) is amended by adding at the end the following new 
subsection:
``(o) HPV Cancer Prevention Public Awareness Campaign.--
``(1) In general.--The Secretary, acting through the 
Director of the Centers for Disease Control and Prevention, 
shall carry out a national campaign to--
``(A) increase awareness of the importance of HPV 
vaccination for preventing HPV-associated cancers;
``(B) combat misinformation about HPV vaccination; 
and
``(C) increase HPV vaccination rates and completion 
of the vaccine series.
``(2) Consultation.--In carrying out the national campaign 
required by paragraph (1), the Secretary shall consult with the 
National Academy of Medicine, including health care providers 
and public health associations, nonprofit organizations 
(including those that represent communities most impacted by 
HPV-associated cancers and communities with low vaccination 
rates), State and local public health departments, elementary 
and secondary education organizations (including student and 
parent organizations), and institutions of higher education, to 
solicit advice on evidence-based information for policy 
development and program development, implementation, and 
evaluation.
``(3) Requirements.--The national campaign required by 
paragraph (1) shall--
``(A) include the use of evidence-based media and 
public engagement;
``(B) be carried out through competitive grants or 
cooperative agreements awarded to 1 or more nonprofit 
entities with a history developing and implementing 
similar campaigns;
``(C) include the development of culturally and 
linguistically competent resources that shall be 
tailored for--
``(i) communities with high rates of--
``(I) unvaccinated individuals, 
including males;
``(II) individuals with high rates 
of cervical cancer and other HPV-
associated cancers (such as Black and 
Hispanic women); and
``(III) populations impacted by the 
increase in oropharynx cancers, 
including active-duty service members 
and veterans;
``(ii) rural communities; and
``(iii) such other communities as the 
Secretary determines appropriate;
``(D) include the dissemination of HPV vaccination 
information and communication resources to health care 
providers and health care facilities (including primary 
care providers, community health centers, dentists, 
obstetricians, and gynecologists), and such providers 
and such facilities for pediatric care, State and local 
public health departments, elementary and secondary 
schools, and colleges and universities;
``(E) be complementary to, and coordinated with, 
any other Federal efforts with respect to--
``(i) HPV vaccination; and
``(ii) screening for HPV-associated 
cancers, including self-collection methods;
``(F) include message testing to identify 
culturally competent and effective messages for 
behavioral change; and
``(G) include the award of grants or cooperative 
agreements to State, local, and Tribal public health 
departments--
``(i) to engage with communities specified 
in subparagraph (C), local education agencies, 
health care providers, community organizations, 
or other groups the Secretary determines are 
appropriate to develop and deliver effective 
strategies to increase HPV vaccination rates; 
and
``(ii) to disseminate culturally and 
linguistically competent resources on the 
National Breast and Cervical Cancer Early 
Detection Program and where an individual can 
access the screenings locally.
``(4) Options for dissemination of information.--The 
national campaign required by paragraph (1) may--
``(A) include the use of--
``(i) social media, television, radio, 
print, the internet, and other media;
``(ii) in person or virtual public 
communications; and
``(iii) recognized, trusted figures;
``(B) be targeted to specific groups and 
communities specified in paragraph (3)(C); and
``(C) include the dissemination of information 
highlighting each of the following:
``(i) Recommended age range to get the HPV 
vaccine.
``(ii) The benefits of getting vaccinated 
against HPV, including the potential to not 
acquire HPV-associated cancers.
``(iii) HPV vaccine safety and the systems 
in place to monitor such safety.
``(5) Authorization of appropriations.--There is authorized 
to be appropriated to carry out this subsection $5,000,000 for 
each of fiscal years 2026 through 2030.''.
(b) Report to Congress.--Not later than September 30, 2027, the 
Secretary of Health and Human Services shall submit to the Committee on 
Energy and Commerce of the House of Representatives and the Committee 
on Health, Education, Labor and Pensions of the Senate a report--
(1) that contains a qualitative assessment of the campaign 
under subsection (o) of section 317 of the Public Health 
Service Act (42 U.S.C. 247b), as added by subsection (a), and 
the activities conducted under such campaign; and
(2) on, with respect to the impact on cancer associated 
with human papillomavirus, the activities conducted under such 
subsection (o).

SEC. 4. BREAST AND CERVICAL CANCER EARLY DETECTION PROGRAM.

(a) In General.--Section 1510(a) of the Public Health Service Act 
(42 U.S.C. 300n-5(a)) is amended by striking ``and $275,000,000 for 
fiscal year 2012'' and inserting ``$275,000,000 for fiscal year 2012, 
and $300,000,000 for each fiscal years 2026 through 2030''.
(b) Coordinating Committee.--Section 1501(d) of the Public Health 
Service Act (42 U.S.C. 300k(d)) is amended--
(1) in the subsection heading, by striking ``2020'' and 
inserting ``2030''; and
(2) by striking ``2020'' and inserting ``2030''.
<all>